An antioxidant contained in red table wine could one day prove effective as protection against radiation from a nuclear attack, according to a study by University of Pittsburgh researchers.
An antioxidant contained in red table wine could one day prove effective as protection against radiation from a nuclear attack, according to a study by University of Pittsburgh researchers.
The University of Pittsburgh's Center for Medical Countermeasures Against Radiation is dedicated to discovering and developing drugs that can be used as quick "antidotes" to mitigate or protect against the effects of radiation exposure in case of a large-scale radiological or nuclear emergency.
These new, small molecules with radioprotective capacity will be required for treatment in case of radiation spills or even as countermeasures against radiological terrorism, said lead investigator Dr. Joel Greenberger, chair of radiation oncology at Pitt's School of Medicine.
Greenberg and colleagues have been investigating the protective properties of resveratrol, a natural antioxidant commonly found in red wine and many plants. The investigators found that resveratrol, when altered with acetyl, proved to shield mouse cells to the effects of radiation. Their results were presented Sept. 23 at the 2008 American Society for Therapeutic Radiology and Oncology meeting in Boston.
"Small molecules that can be easily stored, transported, and administered are optimal for this, and so far acetylated resveratrol fits these requirements well," Greenberger said.
Greenberger's team is conducting further studies to determine if acetylated resveratrol can be used clinically as a radioprotective agent. His group had already made news in 2004 when they discovered the agent JP4-039, which can be delivered directly to mitochondria to resist radiation-induced cell death.
"Currently, there are no drugs on the market that protect against or counteract radiation exposure," Greenberg said. "Our goal is to develop treatments for the general population that are effective and nontoxic."
For more information from the Diagnostic Imaging archives:
Holiday travel can ring more than jingle bells
Dirty bombs: More fear than substance
ACR primer helps prepare for radiological terrorism
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.